Evidence map›Paper›PMID 36980378›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients.

Tanja Eichhorn, Silke Huber, René Weiss, Marie Ebeyer-Masotta, Lucia Lauková, Robert Emprechtinger, Rosa Bellmann-Weiler, Ingo Lorenz, Judith Martini, Markus Pirklbauer and 3 more

Open access · goldFull text read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fullerenol CInternational journal of nanomedicine · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Tanja EichhornDepartment for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.ORCID 0000-0003-4158-026X
Silke HuberInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-7021-1845
René WeissDepartment for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.ORCID 0000-0003-0715-0493
Marie Ebeyer-MasottaDepartment for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.ORCID 0000-0002-2292-7312
Lucia LaukováDepartment for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.
Robert EmprechtingerFaculty of Health and Medicine, University for Continuing Education Krems, 3500 Krems, Austria.
Rosa Bellmann-WeilerDepartment of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-5584-111X
Ingo LorenzDepartment of General and Surgical Critical Care Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Judith MartiniDepartment of Anaesthesia and Intensive Care Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-3656-4591
Markus PirklbauerDepartment of Internal Medicine IV-Nephrology and Hypertension, Medical University Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-1211-0253
Dorothea Orth-HöllerMB-LAB Clinical Microbiology Laboratory, 6020 Innsbruck, Austria.
Reinhard WürznerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6804-442X
Viktoria WeberDepartment for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.ORCID 0000-0002-3963-9077
Innsbruck Medical University · ATUniversität für Weiterbildung Krems · AT

Funding

Austrian Research Promotion Agency 871243FWF Austrian Science Fund W-1253 (HOROS)Lower Austrian Society for Research Funding Organization K3-F-744/005-2019
6 · The paper itself

Abstract

Immunothrombosis, an excessive inflammatory response with simultaneous overactivation of the coagulation system, is a central pathomechanism in sepsis and COVID-19. It is associated with cellular activation, vascular damage, and microvascular thrombosis, which can lead to multiple organ failure and death. Here, we characterized factors related to immunothrombosis in plasma samples from 78 sepsis patients. In the course of routine clinical testing, SARS-CoV-2 was detected in 14 of these patients. Viral infection was associated with a higher mortality. Both, COVID-19 negative and COVID-19 positive sepsis patients showed increased levels of effectors of immunothrombosis, including platelet factor 4, D-dimer, nucleosomes, citrullinated histone H3, high mobility group box-1 protein, as well as phosphatidylserine-expressing platelet-derived extracellular vesicles, compared to healthy controls (

Indexed as

COVID-19extracellular vesiclesimmunothrombosisinflammationsepsis

Identifiers

PMID36980378
PMCPMC10047668
OpenAlexW4324091341

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.